Steris Corp (STE)

$236.60 -1.63 (-0.68%)
Market Cap 23.23B
Revenue (ttm) 5.94B
Net Income (ttm) 782.30M
EPS (ttm) N/A
PE Ratio 22.93
Forward PE 21.54
Profit Margin 13.18%
Debt to Equity Ratio 0.26
Volume 648,200
Avg Vol 812,036
Day's Range N/A - N/A
Shares Out 97.50M
Stochastic %K 82%
Beta 0.91
Analysts Strong Sell
Price Target $259.12

Company Profile

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the pro...

Industry: Medical Devices
Sector: Healthcare
Phone: 440 354 2600
Address:
5960 Heisley Road, Mentor, United States
Parlandoconme
Parlandoconme Aug. 11 at 9:46 AM
$TOMZ The steramist is about to MTGA ! Buy like crazy. $YUM $STE We need safe lettuce and weed bitches.
0 · Reply
OnlyFibs
OnlyFibs Aug. 10 at 11:14 PM
STERIS plc $STE (8h) Bullish Flow: Institutional accumulators are quietly loading shares as $STE builds out its newly authorized $1B share repurchase program and expands its dividend for the 21st consecutive year. absorbing supply right at the lower boundary of a multi-month ascending channel. 🐂 💧 Bull Key Level: $230.00 (Bull confirmation to break local horizontal resistance and accelerate toward upper channel boundary) 🐂 🔥 Bear Key Level: $213.00 (Key structural support floor and ascending trendline anchor to defend) 🐻 ⚠️ Targets: $245.00 / $260.00 💰 🍺 Why: The 8-hour chart displays a textbook ascending pitchfork channel with price bouncing cleanly off lower trendline support. With $982.9M in annual free cash flow providing exceptional balance sheet flexibility and double-digit adjusted EPS growth ($10.17 FY26), holding above $213 keeps the macro bull trend firmly intact. #ste | #stocktrading | #optionsflow | #technicalanalysis | #hovdid
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Aug. 5 at 8:42 PM
$STE Q1 '27 Earnings Results & Recap • Reported GAAP EPS of $2.05 up 13.89% YoY • Reported revenue of $1.49B up 7.30% YoY • STERIS reiterates its fiscal 2027 outlook, anticipating as reported revenue growth of 7-8%, constant currency organic revenue growth of 6-7%, and adjusted earnings per diluted share of $11.10 to $11.30.
0 · Reply
Parlandoconme
Parlandoconme Jul. 30 at 10:42 AM
$TOMZ Stacked a ton of this bad boy. Malto Bene to 6 log kill and no equipment kill. Will be $5/sp in 6 months. $STE $TSLA
0 · Reply
Parlandoconme
Parlandoconme Jul. 24 at 10:39 AM
$TOMZ Buy like crazy now from the clowns that bought high. They never learn. Maybe they graduated from the LEARING center? $TSLA $STE Its all about the patents according to Rick James bitch.
0 · Reply
Parlandoconme
Parlandoconme Jul. 23 at 11:35 AM
$TOMZ This is buy time. My cost basis is $0.37 . Got all my cheap shares from people that bought high and sold low. I like to buy low and sell high. This stock has made me millions. $ECL $STE $TSLA
0 · Reply
BillionerOfKing
BillionerOfKing Jun. 22 at 10:32 PM
$STE Current Stock Price: $200.37 Contracts to trade: $210.0 STE Jul 17 2026 Call Entry: $0.90 Exit: $1.22 ROI: 36% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
NVDAMillionaire
NVDAMillionaire Jun. 10 at 8:30 AM
$STE Really good write-up that perfectly summarizes STE's present situation. So if you want to bring your STE knowledge up to date or just discover STE, this is required reading. https://everyticker.com/quote/STE/analysis/steris-margin-expansion-meets-capital-allocation-excellence-in-infection-prevention-nyse-ste
0 · Reply
Parlandoconme
Parlandoconme Jun. 1 at 3:26 PM
$TOMZ will eclipse the dollar price today. $STE $ECL Twelve million annual will be in rear view mirror next year. Europe,Africa,Canada all moving to this new technology. BENE !
0 · Reply
d_risk
d_risk Jun. 1 at 1:39 PM
$STE - STERIS plc (Ireland) - 10K - Updated Risk Factors STE flags higher exposure to shifting trade rules and USMCA’s 2026 review, new Medicaid and tax uncertainty from the 2025 OBBBA, potential double taxation and GloBE impacts given its Irish parent, expanding ESG and EU/US sustainability reporting burdens, EO-sterilization litigation and settlements, execution risk in smart manufacturing and AI adoption, and greater risk that acquisitions, investments, and realignment initiatives may not deliver expected returns. #HealthcareEquipment #TradePolicyRisk #TaxUncertainty #ESGReporting #AIAdoption 🟢 Added 🟠 Removed https://d-risk.ai/STE/10-K/2026-05-29
0 · Reply
Latest News on STE
Steris price target lowered to $270 from $275 at UBS

2026-08-07T13:07:19.000Z - 5 days ago

Steris price target lowered to $270 from $275 at UBS

STERIS Earnings Call Transcript: Q1 2027

Aug 6, 2026, 9:00 AM EDT - 6 days ago

STERIS Earnings Call Transcript: Q1 2027

STERIS Earnings release: Q1 2027

Aug 6, 2026, 9:00 AM EDT - 6 days ago

STERIS Earnings release: Q1 2027

STERIS Quarterly report: Q1 2027

Aug 6, 2026, 9:00 AM EDT - 6 days ago

STERIS Quarterly report: Q1 2027

Steris announces targeted restructuring plan

2026-08-05T20:42:20.000Z - 7 days ago

Steris announces targeted restructuring plan

Steris reports Q1 adjusted EPS $2.59, consensus $2.49

2026-08-05T20:36:07.000Z - 7 days ago

Steris reports Q1 adjusted EPS $2.59, consensus $2.49

Steris backs FY27 adjusted EPS view of $11.10-$11.30, consensus $11.16

2026-08-05T20:35:26.000Z - 7 days ago

Steris backs FY27 adjusted EPS view of $11.10-$11.30, consensus $11.16

STERIS Announces Financial Results for Fiscal 2027 First Quarter

Aug 5, 2026, 4:30 PM EDT - 7 days ago

STERIS Announces Financial Results for Fiscal 2027 First Quarter

Steris management to meet virtually with KeyBanc

2026-08-05T19:10:39.000Z - 7 days ago

Steris management to meet virtually with KeyBanc

Steris to invest $600M in North Carolina facility

2026-08-05T13:53:21.000Z - 7 days ago

Steris to invest $600M in North Carolina facility

Steris to invest $600 million in new North Carolina chemicals manufacturing hub

Aug 5, 2026, 9:27 AM EDT - 7 days ago

Steris to invest $600 million in new North Carolina chemicals manufacturing hub

STERIS To Invest $600 Million to Build a Formulated Chemistries Manufacturing and Distribution Center of Excellence in North Carolina

Aug 5, 2026, 8:45 AM EDT - 7 days ago

STERIS To Invest $600 Million to Build a Formulated Chemistries Manufacturing and Distribution Center of Excellence in North Carolina

Steris increases quarterly dividend to 69c per share

2026-07-30T20:50:54.000Z - 13 days ago

Steris increases quarterly dividend to 69c per share

STERIS Raises Dividend to $0.69 per share

Jul 30, 2026, 4:30 PM EDT - 13 days ago

STERIS Raises Dividend to $0.69 per share

Steris initiated with a Buy at UBS

2026-07-28T10:35:28.000Z - 15 days ago

Steris initiated with a Buy at UBS

STERIS to Host a Conference Call for Fiscal 2027 First Quarter on August 6, 2026

Jul 27, 2026, 4:30 PM EDT - 16 days ago

STERIS to Host a Conference Call for Fiscal 2027 First Quarter on August 6, 2026

STERIS Proxy statement: Proxy filing

Jun 11, 2026, 8:00 AM EDT - 2 months ago

STERIS Proxy statement: Proxy filing

STERIS Proxy statement: Proxy filing

Jun 11, 2026, 8:00 AM EDT - 2 months ago

STERIS Proxy statement: Proxy filing

Steris price target lowered to $269 from $291 at KeyBanc

2026-05-13T11:31:52.000Z - 3 months ago

Steris price target lowered to $269 from $291 at KeyBanc

STERIS Earnings Call Transcript: Q4 2026

May 12, 2026, 9:00 AM EDT - 3 months ago

STERIS Earnings Call Transcript: Q4 2026

STERIS Earnings release: Q4 2026

May 12, 2026, 9:00 AM EDT - 3 months ago

STERIS Earnings release: Q4 2026

STERIS Annual report: Q4 2026

May 12, 2026, 9:00 AM EDT - 3 months ago

STERIS Annual report: Q4 2026

STERIS Slides: Investor presentation

May 12, 2026, 7:00 AM EDT - 3 months ago

STERIS Slides: Investor presentation

Steris reports Q4 adjusted EPS $2.83, consensus $2.85

2026-05-11T23:52:15.000Z - 3 months ago

Steris reports Q4 adjusted EPS $2.83, consensus $2.85

Steris sees FY27 adjusted EPS $11.10-$11.30, consensus $11.08

2026-05-11T23:43:33.000Z - 3 months ago

Steris sees FY27 adjusted EPS $11.10-$11.30, consensus $11.08

Steris forecasts 2027 profit above estimates, banks on procedure-driven demand

May 11, 2026, 6:33 PM EDT - 3 months ago

Steris forecasts 2027 profit above estimates, banks on procedure-driven demand

STERIS Announces Financial Results for Fiscal 2026 Fourth Quarter and Full Year

May 11, 2026, 4:30 PM EDT - 3 months ago

STERIS Announces Financial Results for Fiscal 2026 Fourth Quarter and Full Year

STERIS Appoints Pierre Boulud to Board of Directors

May 7, 2026, 4:30 PM EDT - 3 months ago

STERIS Appoints Pierre Boulud to Board of Directors

STERIS Announces Dividend of $0.63 per share

May 5, 2026, 4:30 PM EDT - 3 months ago

STERIS Announces Dividend of $0.63 per share

STERIS to Host a Conference Call for Fiscal 2026 Fourth Quarter and Full Year Results on May 12, 2026

Apr 21, 2026, 4:30 PM EDT - 4 months ago

STERIS to Host a Conference Call for Fiscal 2026 Fourth Quarter and Full Year Results on May 12, 2026

STERIS Earnings Call Transcript: Q3 2026

Feb 5, 2026, 9:00 AM EST - 6 months ago

STERIS Earnings Call Transcript: Q3 2026

STERIS Quarterly report: Q3 2026

Feb 5, 2026, 9:00 AM EST - 6 months ago

STERIS Quarterly report: Q3 2026

STERIS Earnings release: Q3 2026

Feb 5, 2026, 9:00 AM EST - 6 months ago

STERIS Earnings release: Q3 2026

Steris sees FY26 adjusted EPS $10.15-$10.30, consensus $10.21

2026-02-04T21:40:54.000Z - 6 months ago

Steris sees FY26 adjusted EPS $10.15-$10.30, consensus $10.21

Steris reports Q3 adjusted EPS $2.53, consensus $2.53

2026-02-04T21:35:27.000Z - 6 months ago

Steris reports Q3 adjusted EPS $2.53, consensus $2.53

STERIS Announces Financial Results for Fiscal 2026 Third Quarter

Feb 4, 2026, 4:30 PM EST - 6 months ago

STERIS Announces Financial Results for Fiscal 2026 Third Quarter

STERIS to Host a Conference Call for Fiscal 2026 Third Quarter Results on February 5, 2026

Jan 21, 2026, 4:30 PM EST - 7 months ago

STERIS to Host a Conference Call for Fiscal 2026 Third Quarter Results on February 5, 2026

METTLER TOLEDO Announces Michael J. Tokich to Join Board of Directors

Jan 20, 2026, 4:30 PM EST - 7 months ago

METTLER TOLEDO Announces Michael J. Tokich to Join Board of Directors

MTD

STERIS Earnings Call Transcript: Q2 2026

Nov 6, 2025, 9:00 AM EST - 9 months ago

STERIS Earnings Call Transcript: Q2 2026

STERIS Quarterly report: Q2 2026

Nov 6, 2025, 9:00 AM EST - 9 months ago

STERIS Quarterly report: Q2 2026

STERIS Earnings release: Q2 2026

Nov 6, 2025, 9:00 AM EST - 9 months ago

STERIS Earnings release: Q2 2026

Steris raises FY26 adjusted EPS view to $10.15-$10.30 from $9.90-$10.15

2025-11-05T23:10:53.000Z - 10 months ago

Steris raises FY26 adjusted EPS view to $10.15-$10.30 from $9.90-$10.15

Steris reports Q2 adjusted EPS $2.47, consensus $2.35

2025-11-05T23:05:17.000Z - 10 months ago

Steris reports Q2 adjusted EPS $2.47, consensus $2.35

STERIS Announces Financial Results for Fiscal 2026 Second Quarter

Nov 5, 2025, 4:30 PM EST - 10 months ago

STERIS Announces Financial Results for Fiscal 2026 Second Quarter

STERIS to Host a Conference Call for Fiscal 2026 Second Quarter Results on November 6, 2025

Oct 21, 2025, 4:30 PM EDT - 10 months ago

STERIS to Host a Conference Call for Fiscal 2026 Second Quarter Results on November 6, 2025

Steris management to meet with Piper Sandler

2025-09-29T20:50:19.000Z - 11 months ago

Steris management to meet with Piper Sandler

Steris management to meet virtually with KeyBanc

2025-08-19T19:25:17.000Z - 1 year ago

Steris management to meet virtually with KeyBanc

STERIS Earnings Call Transcript: Q1 2026

Aug 7, 2025, 9:00 AM EDT - 1 year ago

STERIS Earnings Call Transcript: Q1 2026

STERIS Quarterly report: Q1 2026

Aug 7, 2025, 9:00 AM EDT - 1 year ago

STERIS Quarterly report: Q1 2026

STERIS Earnings release: Q1 2026

Aug 7, 2025, 9:00 AM EDT - 1 year ago

STERIS Earnings release: Q1 2026

STERIS Announces Chief Financial Officer Transition

Aug 6, 2025, 4:31 PM EDT - 1 year ago

STERIS Announces Chief Financial Officer Transition

STERIS Announces Financial Results for Fiscal 2026 First Quarter

Aug 6, 2025, 4:30 PM EDT - 1 year ago

STERIS Announces Financial Results for Fiscal 2026 First Quarter

STERIS Raises Dividend to $0.63 per share

Jul 30, 2025, 4:30 PM EDT - 1 year ago

STERIS Raises Dividend to $0.63 per share

STERIS to Host a Conference Call for Fiscal 2026 First Quarter Results on August 7, 2025

Jul 22, 2025, 4:30 PM EDT - 1 year ago

STERIS to Host a Conference Call for Fiscal 2026 First Quarter Results on August 7, 2025

STERIS Proxy statement: Proxy Filing

Jul 3, 2025, 8:00 AM EDT - 1 year ago

STERIS Proxy statement: Proxy Filing

STERIS Proxy statement: Proxy Filing

Jun 12, 2025, 8:00 AM EDT - 1 year ago

STERIS Proxy statement: Proxy Filing

STERIS Proxy statement: Proxy Filing

Jun 12, 2025, 8:00 AM EDT - 1 year ago

STERIS Proxy statement: Proxy Filing

STERIS Slides: Investor Presentation

May 27, 2025, 7:00 AM EDT - 1 year ago

STERIS Slides: Investor Presentation

U.S. Gynecological Chairs and Tables Market Size, Share & Trends Analysis Report 2025-2030 Featuring STERIS, The Brewer Company, Midmark Corp. (Ritter Midmark), Clinton Industries, UMF Medical and More

May 20, 2025, 7:57 AM EDT - 1 year ago

U.S. Gynecological Chairs and Tables Market Size, Share & Trends Analysis Report 2025-2030 Featuring STERIS, The Brewer Company, Midmark Corp. (Ritter Midmark), Clinton Industries, UMF Medical and More

Why This Medical Equipment Stock Is Today's S&P 500 Winner

May 15, 2025, 12:39 PM EDT - 1 year ago

Why This Medical Equipment Stock Is Today's S&P 500 Winner

STERIS Earnings Call Transcript: Q4 2025

May 15, 2025, 9:00 AM EDT - 1 year ago

STERIS Earnings Call Transcript: Q4 2025

STERIS Annual report: Q4 2025

May 15, 2025, 9:00 AM EDT - 1 year ago

STERIS Annual report: Q4 2025

STERIS Earnings release: Q4 2025

May 15, 2025, 9:00 AM EDT - 1 year ago

STERIS Earnings release: Q4 2025

Steris forecasts annual profit above estimates on strong medical equipment sales

May 14, 2025, 5:26 PM EDT - 1 year ago

Steris forecasts annual profit above estimates on strong medical equipment sales

Steris Fiscal Fourth-Quarter 2025 Financial Results: Just the Numbers

May 14, 2025, 5:06 PM EDT - 1 year ago

Steris Fiscal Fourth-Quarter 2025 Financial Results: Just the Numbers

STERIS Announces Financial Results for Fiscal 2025 Fourth Quarter and Full Year

May 14, 2025, 4:30 PM EDT - 1 year ago

STERIS Announces Financial Results for Fiscal 2025 Fourth Quarter and Full Year

STERIS Declares Dividend of $0.57 per share

May 7, 2025, 4:30 PM EDT - 1 year ago

STERIS Declares Dividend of $0.57 per share

STERIS to Host a Conference Call for Fiscal 2025 Fourth Quarter and Full Year Financial Results on May 15, 2025

Apr 22, 2025, 4:30 PM EDT - 1 year ago

STERIS to Host a Conference Call for Fiscal 2025 Fourth Quarter and Full Year Financial Results on May 15, 2025

STERIS Slides: Investor Presentation

Feb 12, 2025, 7:00 AM EST - 1 year ago

STERIS Slides: Investor Presentation

STERIS Earnings Call Transcript: Q3 2025

Feb 6, 2025, 9:00 AM EST - 1 year ago

STERIS Earnings Call Transcript: Q3 2025

STERIS Quarterly report: Q3 2025

Feb 6, 2025, 9:00 AM EST - 1 year ago

STERIS Quarterly report: Q3 2025

STERIS Earnings release: Q3 2025

Feb 6, 2025, 9:00 AM EST - 1 year ago

STERIS Earnings release: Q3 2025

Steris lowers annual profit forecast due to a stronger dollar

Feb 5, 2025, 6:43 PM EST - 1 year ago

Steris lowers annual profit forecast due to a stronger dollar

STERIS Announces Financial Results for Fiscal 2025 Third Quarter

Feb 5, 2025, 4:30 PM EST - 1 year ago

STERIS Announces Financial Results for Fiscal 2025 Third Quarter

STERIS to Host a Conference Call for Fiscal 2025 Third Quarter Financial Results on February 6, 2025

Jan 22, 2025, 4:30 PM EST - 1 year ago

STERIS to Host a Conference Call for Fiscal 2025 Third Quarter Financial Results on February 6, 2025

STERIS Announces Outcome of Ethylene Oxide Trial

Jan 21, 2025, 6:30 AM EST - 1 year ago

STERIS Announces Outcome of Ethylene Oxide Trial

STERIS Earnings Call Transcript: Q2 2025

Nov 7, 2024, 9:00 AM EST - 1 year ago

STERIS Earnings Call Transcript: Q2 2025

STERIS Quarterly report: Q2 2025

Nov 7, 2024, 9:00 AM EST - 1 year ago

STERIS Quarterly report: Q2 2025

STERIS Earnings release: Q2 2025

Nov 7, 2024, 9:00 AM EST - 1 year ago

STERIS Earnings release: Q2 2025

Steris beats quarterly estimates on continued demand for medical procedures

Nov 6, 2024, 5:44 PM EST - 1 year ago

Steris beats quarterly estimates on continued demand for medical procedures

STERIS Announces Financial Results for Fiscal 2025 Second Quarter

Nov 6, 2024, 4:30 PM EST - 1 year ago

STERIS Announces Financial Results for Fiscal 2025 Second Quarter

STERIS to Host a Conference Call for Fiscal 2025 Second Quarter Financial Results on November 7, 2024

Oct 23, 2024, 4:30 PM EDT - 1 year ago

STERIS to Host a Conference Call for Fiscal 2025 Second Quarter Financial Results on November 7, 2024

STERIS plc (STE) Enters New $1.1 Billion Revolving Credit Agreement

Oct 9, 2024, 3:39 PM EDT - 2 years ago

STERIS plc (STE) Enters New $1.1 Billion Revolving Credit Agreement

STERIS Transcript: Morgan Stanley 22nd Annual Global Healthcare Conference

Sep 4, 2024, 1:50 PM EDT - 2 years ago

STERIS Transcript: Morgan Stanley 22nd Annual Global Healthcare Conference

STERIS to Present at the Morgan Stanley Healthcare Conference

Aug 26, 2024, 4:30 PM EDT - 2 years ago

STERIS to Present at the Morgan Stanley Healthcare Conference

STERIS Earnings Call Transcript: Q1 2025

Aug 7, 2024, 9:00 AM EDT - 2 years ago

STERIS Earnings Call Transcript: Q1 2025

STERIS Quarterly report: Q1 2025

Aug 7, 2024, 9:00 AM EDT - 2 years ago

STERIS Quarterly report: Q1 2025

STERIS Earnings release: Q1 2025

Aug 7, 2024, 9:00 AM EDT - 2 years ago

STERIS Earnings release: Q1 2025

STERIS Announces Financial Results for Fiscal 2025 First Quarter

Aug 6, 2024, 4:30 PM EDT - 2 years ago

STERIS Announces Financial Results for Fiscal 2025 First Quarter

STERIS Raises Dividend to $0.57 per share

Jul 31, 2024, 4:30 PM EDT - 2 years ago

STERIS Raises Dividend to $0.57 per share

STERIS to Host a Conference Call for Fiscal 2025 First Quarter Financial Results on August 7, 2024

Jul 23, 2024, 4:30 PM EDT - 2 years ago

STERIS to Host a Conference Call for Fiscal 2025 First Quarter Financial Results on August 7, 2024

STERIS Proxy statement: Proxy Filing

Jun 12, 2024, 8:00 AM EDT - 2 years ago

STERIS Proxy statement: Proxy Filing

STERIS Proxy statement: Proxy Filing

Jun 12, 2024, 8:00 AM EDT - 2 years ago

STERIS Proxy statement: Proxy Filing

PEAK ROCK CAPITAL AFFILIATE COMPLETES PREVIOUSLY ANNOUNCED ACQUISITION OF HUFRIEDYGROUP

Jun 3, 2024, 7:00 AM EDT - 2 years ago

PEAK ROCK CAPITAL AFFILIATE COMPLETES PREVIOUSLY ANNOUNCED ACQUISITION OF HUFRIEDYGROUP

STERIS Earnings Call Transcript: Q4 2024

May 9, 2024, 9:00 AM EDT - 2 years ago

STERIS Earnings Call Transcript: Q4 2024

STERIS Annual report: Q4 2024

May 9, 2024, 9:00 AM EDT - 2 years ago

STERIS Annual report: Q4 2024

STERIS Earnings release: Q4 2024

May 9, 2024, 9:00 AM EDT - 2 years ago

STERIS Earnings release: Q4 2024

STERIS Announces Financial Results for Fiscal 2024 Fourth Quarter and Full Year

May 8, 2024, 4:30 PM EDT - 2 years ago

STERIS Announces Financial Results for Fiscal 2024 Fourth Quarter and Full Year

STERIS Announces Dividend of $0.52 per share

May 1, 2024, 4:30 PM EDT - 2 years ago

STERIS Announces Dividend of $0.52 per share

STERIS to Host a Conference Call for Fiscal 2024 Fourth Quarter and Full Year Financial Results on May 9, 2024

Apr 24, 2024, 4:30 PM EDT - 2 years ago

STERIS to Host a Conference Call for Fiscal 2024 Fourth Quarter and Full Year Financial Results on May 9, 2024

PEAK ROCK CAPITAL AFFILIATE SIGNS DEFINITIVE AGREEMENT TO ACQUIRE HUFRIEDYGROUP

Apr 11, 2024, 7:30 AM EDT - 2 years ago

PEAK ROCK CAPITAL AFFILIATE SIGNS DEFINITIVE AGREEMENT TO ACQUIRE HUFRIEDYGROUP

STERIS to Sell Dental Segment to an affiliate of Peak Rock Capital

Apr 11, 2024, 6:58 AM EDT - 2 years ago

STERIS to Sell Dental Segment to an affiliate of Peak Rock Capital

STERIS Earnings Call Transcript: Q3 2024

Feb 8, 2024, 9:00 AM EST - 2 years ago

STERIS Earnings Call Transcript: Q3 2024

STERIS Quarterly report: Q3 2024

Feb 8, 2024, 9:00 AM EST - 2 years ago

STERIS Quarterly report: Q3 2024

STERIS Earnings release: Q3 2024

Feb 8, 2024, 9:00 AM EST - 2 years ago

STERIS Earnings release: Q3 2024

Steris beats third-quarter estimates on strong medical procedure demand

Feb 7, 2024, 6:35 PM EST - 2 years ago

Steris beats third-quarter estimates on strong medical procedure demand

STERIS Announces Financial Results for Fiscal 2024 Third Quarter

Feb 7, 2024, 4:30 PM EST - 2 years ago

STERIS Announces Financial Results for Fiscal 2024 Third Quarter

STERIS to Host a Conference Call for Fiscal 2024 Third Quarter Financial Results on February 8, 2024

Jan 23, 2024, 4:30 PM EST - 2 years ago

STERIS to Host a Conference Call for Fiscal 2024 Third Quarter Financial Results on February 8, 2024

STERIS Earnings Call Transcript: Q2 2024

Nov 8, 2023, 9:00 AM EST - 3 years ago

STERIS Earnings Call Transcript: Q2 2024

STERIS Quarterly report: Q2 2024

Nov 8, 2023, 9:00 AM EST - 3 years ago

STERIS Quarterly report: Q2 2024

STERIS Earnings release: Q2 2024

Nov 8, 2023, 9:00 AM EST - 3 years ago

STERIS Earnings release: Q2 2024

STERIS Announces Financial Results for Fiscal 2024 Second Quarter

Nov 7, 2023, 4:30 PM EST - 3 years ago

STERIS Announces Financial Results for Fiscal 2024 Second Quarter

STERIS to Host a Conference Call for Fiscal 2024 Second Quarter Financial Results on November 8, 2023

Oct 24, 2023, 4:30 PM EDT - 3 years ago

STERIS to Host a Conference Call for Fiscal 2024 Second Quarter Financial Results on November 8, 2023

STERIS Transcript: Morgan Stanley 21st Annual Global Healthcare Conference 2023

Sep 13, 2023, 8:10 AM EDT - 3 years ago

STERIS Transcript: Morgan Stanley 21st Annual Global Healthcare Conference 2023

STERIS Completes the Acquisition of Surgical Instrumentation Assets from BD

Aug 2, 2023, 4:30 PM EDT - 3 years ago

STERIS Completes the Acquisition of Surgical Instrumentation Assets from BD

Parlandoconme
Parlandoconme Aug. 11 at 9:46 AM
$TOMZ The steramist is about to MTGA ! Buy like crazy. $YUM $STE We need safe lettuce and weed bitches.
0 · Reply
OnlyFibs
OnlyFibs Aug. 10 at 11:14 PM
STERIS plc $STE (8h) Bullish Flow: Institutional accumulators are quietly loading shares as $STE builds out its newly authorized $1B share repurchase program and expands its dividend for the 21st consecutive year. absorbing supply right at the lower boundary of a multi-month ascending channel. 🐂 💧 Bull Key Level: $230.00 (Bull confirmation to break local horizontal resistance and accelerate toward upper channel boundary) 🐂 🔥 Bear Key Level: $213.00 (Key structural support floor and ascending trendline anchor to defend) 🐻 ⚠️ Targets: $245.00 / $260.00 💰 🍺 Why: The 8-hour chart displays a textbook ascending pitchfork channel with price bouncing cleanly off lower trendline support. With $982.9M in annual free cash flow providing exceptional balance sheet flexibility and double-digit adjusted EPS growth ($10.17 FY26), holding above $213 keeps the macro bull trend firmly intact. #ste | #stocktrading | #optionsflow | #technicalanalysis | #hovdid
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Aug. 5 at 8:42 PM
$STE Q1 '27 Earnings Results & Recap • Reported GAAP EPS of $2.05 up 13.89% YoY • Reported revenue of $1.49B up 7.30% YoY • STERIS reiterates its fiscal 2027 outlook, anticipating as reported revenue growth of 7-8%, constant currency organic revenue growth of 6-7%, and adjusted earnings per diluted share of $11.10 to $11.30.
0 · Reply
Parlandoconme
Parlandoconme Jul. 30 at 10:42 AM
$TOMZ Stacked a ton of this bad boy. Malto Bene to 6 log kill and no equipment kill. Will be $5/sp in 6 months. $STE $TSLA
0 · Reply
Parlandoconme
Parlandoconme Jul. 24 at 10:39 AM
$TOMZ Buy like crazy now from the clowns that bought high. They never learn. Maybe they graduated from the LEARING center? $TSLA $STE Its all about the patents according to Rick James bitch.
0 · Reply
Parlandoconme
Parlandoconme Jul. 23 at 11:35 AM
$TOMZ This is buy time. My cost basis is $0.37 . Got all my cheap shares from people that bought high and sold low. I like to buy low and sell high. This stock has made me millions. $ECL $STE $TSLA
0 · Reply
BillionerOfKing
BillionerOfKing Jun. 22 at 10:32 PM
$STE Current Stock Price: $200.37 Contracts to trade: $210.0 STE Jul 17 2026 Call Entry: $0.90 Exit: $1.22 ROI: 36% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
NVDAMillionaire
NVDAMillionaire Jun. 10 at 8:30 AM
$STE Really good write-up that perfectly summarizes STE's present situation. So if you want to bring your STE knowledge up to date or just discover STE, this is required reading. https://everyticker.com/quote/STE/analysis/steris-margin-expansion-meets-capital-allocation-excellence-in-infection-prevention-nyse-ste
0 · Reply
Parlandoconme
Parlandoconme Jun. 1 at 3:26 PM
$TOMZ will eclipse the dollar price today. $STE $ECL Twelve million annual will be in rear view mirror next year. Europe,Africa,Canada all moving to this new technology. BENE !
0 · Reply
d_risk
d_risk Jun. 1 at 1:39 PM
$STE - STERIS plc (Ireland) - 10K - Updated Risk Factors STE flags higher exposure to shifting trade rules and USMCA’s 2026 review, new Medicaid and tax uncertainty from the 2025 OBBBA, potential double taxation and GloBE impacts given its Irish parent, expanding ESG and EU/US sustainability reporting burdens, EO-sterilization litigation and settlements, execution risk in smart manufacturing and AI adoption, and greater risk that acquisitions, investments, and realignment initiatives may not deliver expected returns. #HealthcareEquipment #TradePolicyRisk #TaxUncertainty #ESGReporting #AIAdoption 🟢 Added 🟠 Removed https://d-risk.ai/STE/10-K/2026-05-29
0 · Reply
Parlandoconme
Parlandoconme May. 29 at 11:14 AM
$TOMZ Spraying work areas set up to protect HC workers in Ebola zone. $STE $ECL Next thing you know,will be trading over a buck? Wonder if BSL3-4 in USA use Steramist? Buy.
0 · Reply
KopOut
KopOut May. 27 at 1:55 PM
$STE position started
0 · Reply
Parlandoconme
Parlandoconme May. 26 at 5:51 PM
$TOMZ Insiders know more about the merger than outsiders. HEHEHE. $STE $ECL Only Steramist can do what it can do. Buy.Buy.Buy again.
0 · Reply
Parlandoconme
Parlandoconme May. 19 at 2:17 PM
$TOMZ Spray the Ebola mio amico. $STE EPA and CDC love Steramist. World Health Org needs to jump on this threat.
0 · Reply
MarketBeat
MarketBeat May. 15 at 10:12 AM
https://marketbeat.com/a/8656093/ $STE STERIS Q4 Earnings Call Highlights
0 · Reply
Parlandoconme
Parlandoconme May. 15 at 9:36 AM
$TOMZ In Italia, Steramist viene adottato nei laboratori di biotecnologia. BASTA !!! $STE
0 · Reply
EarningsInsider
EarningsInsider May. 12 at 2:01 PM
https://www.marketbeat.com/earnings/reports/2026-5-11-steris-plc-stock/ $STE STERIS Earnings Transcript
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 11 at 8:45 PM
$STE Q4 '26 Earnings Results & Recap • Reported GAAP EPS of $2.25 up 52.03% YoY • Reported revenue of $1.59B up 7.28% YoY • STERIS anticipates fiscal 2027 as reported revenue to increase 7-8% and adjusted diluted EPS to range from $11.10 to $11.30, an increase of 9-11%. Free cash flow is expected to be approximately $850 million for Steris Plc.
0 · Reply
DonCorleone77
DonCorleone77 May. 11 at 8:43 PM
$STE Steris sees FY27 adjusted EPS $11.10-$11.30, consensus $11.08 Sees FY27 revenue growth 7%-8% from $5.9B, consensus $6.31B. Sees FY27 CapEx $375M.
0 · Reply
DonCorleone77
DonCorleone77 May. 11 at 8:40 PM
$STE Steris reports Q4 adjusted EPS $2.83, consensus $2.85 Reports Q4 revenue $1.6B, consensus $1.6B. "FY26 was another record year," said CEO Dan Carestio. "Our diversified Customer base and growth in procedure volumes continue to drive our performance. We appreciate the efforts of our global Associates who continue to put our Customers first. As we look ahead, we are excited for what is to come as we capitalize on our unique ability to help our Customers enable procedural growth, deliver quality outcomes and drive compliance with standardization and optimization."
0 · Reply
Huck18
Huck18 May. 11 at 8:36 PM
$STE A miss and a Rise, vs. last Q the opposite ... Funny but Expected at this low price
0 · Reply